Skip to main content
. 2022 Apr 13;23(6):170. doi: 10.3892/ol.2022.13290

Figure 2.

Figure 2.

Tepotinib suppresses the EMT process of melanoma cells. The expression levels of EMT-related proteins (E-cadherin, N-cadherin and vimentin) in WM451 cells treated with or without 10 ng/ml tepotinib were evaluated with western blot analysis. ***P<0.001 vs. control (DMSO) group. EMT, epithelial-mesenchymal transition.